ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2320

Multimorbidity Is Associated with Hip Fractures in Both Women and Men and across Different Races

Shreyasee Amin1, Elizabeth J. Atkinson2 and Sundeep Khosla2, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Comorbidity, fracture risk and race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Multimorbidity, the coexistence of 2 or more chronic conditions, is associated with increased disability and poor functional status, and may serve as an important clinical marker for hip fracture risk. We examined the role of multimorbidity on hip fracture risk and whether this differed between women and men, or by race.

Methods: Using de-identified administrative claims data from a large commercial insurance database, we identified both women and men aged ≥50 yrs who had a hip fracture between Jan 1, 2006-Dec 31, 2016, and had at least 1 yr health plan coverage pre-fracture. Subjects without known hip fracture were matched to cases exactly on sex, age, race, year, geographic region, and insurance; they were also required to have at least 1 yr health plan coverage pre-index date. Diagnostic codes and medications were captured for the year prior to fracture/index date. Using the score from the Elixhauser Comorbidity Index (Elix Index), a set of 31 comorbidities, we categorized subjects into 3 groups (0-1, 2-3, and ≥4) and used conditional logistic regression to examine the association with hip fracture. We focused on subjects identified as White, Black or Asian, and examined women and men separately.

Results: We studied 50,136 White/5,770 Black/1,130 Asian women (median age [IQR], yrs: 79 [72, 83]/ 78 [71, 83]/ 79 [71, 83], respectively) and 22,329 White/2,419 Black/451 Asian men (median age [IQR], yrs: 77 [66, 82]/ 75 [66, 81]/ 78 [67, 83], respectively) with hip fractures and an equal number of matched controls. Compared to the referent group (Elix Index 0-1), higher Elix Index was associated with increased hip fracture risk with findings similar in women and men and across races studied (Table). In further analyses with a gradient boosting model, a higher Elix Index ranked as the top influence on hip fracture risk over the individual 31 comorbidities (date not shown). In a multivariable penalized logistic regression model, the addition of medication categories to the 31 comorbidities did not contribute additional information on hip fracture risk (data not shown).

Conclusion: Multimorbidity, as assessed using the Elix Index, is associated with an elevated risk for hip fracture, in both women and men, and across races studied. A higher number of co-existing chronic conditions is associated with an even greater risk of hip fracture. Further work is necessary on determining whether specific combinations of comorbidities have a greater impact on risk.

 


Odds Ratio (OR) and 95% Confidence Interval (95% CI) for Hip Fractures by Elixhauser Comorbidity Index (Elix Index)

 

 

White

Black

Asian

 

Hip Fracture

OR (95% CI)

Hip Fracture

OR (95% CI)

Hip Fracture

OR (95% CI)

 

No

Yes

 

No

Yes

 

No

Yes

 

Women

 

 

 

 

 

 

 

 

 

N

50,136

50,136

 

5,770

5,770

 

1,130

1,130

 

Elix Index

 

 

 

 

 

 

 

 

 

  0-1

30.9%

12.2%

referent

25.0%

9.4%

referent

30.4%

15.4%

referent

  2-3

34.4%

27.5%

2.2 (2.1-2.3)

35.4%

24.7%

2.0 (1.8-2.3)

38.5%

28.0%

1.7 (1.3-2.2)

  ≥ 4

34.7%

60.3%

5.1 (4.9-5.3)

39.6%

66.0%

5.1 (4.5-5.8)

31.2%

56.6%

4.5 (3.5-5.9)

 

 

 

 

 

 

 

 

 

 

Men

 

N

22,329

22,329

 

2,419

2419

 

451

451

 

Elix Index

 

 

 

 

 

 

 

 

 

  0-1

37.0%

14.5%

referent

30.0%

11.3%

referent

37.0%

17.3%

referent

  2-3

32.5%

25.0%

2.3 (2.2-2.5)

34.4%

23.2%

2.0 (1.7-2.5)

31.7%

31.9%

2.5 (1.7-3.7)

  ≥ 4

30.5%

60.5%

6.8 (6.4-7.3)

35.6%

65.4%

5.8 (4.8-7.1)

31.3%

50.8%

4.5 (3.0-6.7)

 


Disclosure: S. Amin, None; E. J. Atkinson, None; S. Khosla, None.

To cite this abstract in AMA style:

Amin S, Atkinson EJ, Khosla S. Multimorbidity Is Associated with Hip Fractures in Both Women and Men and across Different Races [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/multimorbidity-is-associated-with-hip-fractures-in-both-women-and-men-and-across-different-races/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multimorbidity-is-associated-with-hip-fractures-in-both-women-and-men-and-across-different-races/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology